Detalles de la búsqueda
1.
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety.
Mol Ther
; 26(3): 917-931, 2018 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29433935
2.
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Blood
; 128(1): 45-54, 2016 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27129325
3.
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.
Hepatology
; 68(6): 2434-2437, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014500
4.
Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID.
Orphanet J Rare Dis
; 13(1): 49, 2018 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29625577
5.
Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
Hum Gene Ther Clin Dev
; 28(1): 17-27, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28319446
6.
The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.
Pain
; 132(1-2): 132-41, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17659837
Resultados
1 -
6
de 6
1
Próxima >
>>